Learn more

APOGENIX GMBH

Overview
  • Total Patents
    107
  • GoodIP Patent Rank
    52,832
About

APOGENIX GMBH has a total of 107 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are APPLIED MOLECULAR EVOLUTION, ESBATECH AN ALCON BIOMEDICAL R and ESBATECH ALCON BIOMED RES UNIT.

Patent filings per year

Chart showing APOGENIX GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hill Oliver 54
#2 Gieffers Christian 53
#3 Thiemann Meinolf 50
#4 Fricke Harald 15
#5 Todaro Matilde 13
#6 Stassi Giorgio 13
#7 Oliver Hill 8
#8 Walczak Henning 8
#9 Branschaedel Marcus 8
#10 Meinolf Thiemann 8

Latest patents

Publication Filing date Title
WO2015197874A2 Combination of cd95/cd95l inhibition and cancer immunotherapy
WO2015165973A1 Diagnostic anti-cd95l antibody
JP2015143270A Fusion proteins forming trimers
JP2014218510A Fusion proteins forming trimers
BR112015027249A2 cancer diagnosis method
US2015166633A1 Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof
US2010111969A1 Il-4 receptor and il-13 as prognostic markers for colon and pancreas tumors
CA2910512A1 Tnfsf single chain molecules
EP2540740A2 Multimeric TNF receptors
AU2009231482A1 Binding agents directed against IL-4 receptor for the treatment of tumors, inflammatory and immunological disorders
US2009196868A1 Methods and compositions for preventing radiation-induced pneumonitis
EP2484691A1 TNF superfamily collectin fusion proteins
WO2008101671A2 Il-4 fc fusion proteins
WO2008003514A2 Human il-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy
EP2009022A1 Trimeric death ligands with enhanced activity (tenascin)
BRPI0713484A2 cytokine differential expression in human cancer
AU2007228943A1 Antibody specific for human IL-4 for the treament of cancer
EP1894940A1 TNF superfamily fusion proteins
US2007292389A1 Method for the Purification and Amplification of Tumoral Stem Cells
CA2520138A1 Improved fc fusion proteins